Skip to main content
Caplight Logo









CuroNZ Limited

CuroNZ Limited

Private
New ZealandHealthcare & Life Scienceshttps://curonz.com/

Last Round

Grant

Dec 11, 2015

Total Funding Raised

$960,000

Company Overview

CuroNZ Limited is a clinical-stage biotechnology company that develops a platform of peptide drugs for the treatment of severe neurodegenerative diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

biotechnologypeptide therapeuticsCNS disordersepilepsy treatmentneuroprotectiondrug discoveryclinical trialsblood-brain barrierneuroregenerationbiotech startupdrug out-licensingcentral nervous systemCNSbiotech pipelinepharma partnering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CuroNZ Limited Comparables

Compare CuroNZ Limited with similar companies based on industry and business-model similarity.

CuroNZ Limited comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genervon Biopharmaceuticals
78%
EpilepsyGTx
73%
Ovid Therapeutics Inc.
72%

CuroNZ Limited Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 11, 2015
GrantOct 14, 2013
DebtJul 8, 2011
AngelMay 1, 2010
SeedDec 18, 2009

CuroNZ Limited Investors

Notable investors and investment history

CuroNZ Limited investors
InvestorRounds
Callaghan InnovationGrant
National MS SocietyGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Monthly visitors grew 361% MoM, reaching 6.8K.

  • Oct 14, 2013

    $540K grant received from the National MS Society.

CuroNZ Limited Filings

Explore SEC and related filing metadata, where available.

CuroNZ Limited filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CuroNZ Limited's valuation, stock price, and market status.

Is Curonz Limited a public or private company?

Curonz Limited is a private company.

What is the current stock price of Curonz Limited?

Curonz Limited is a private company with no public stock price. No recent secondary market data is available.

How much is Curonz Limited worth (valuation)?

Valuation information for Curonz Limited is not publicly available.

Can I buy Curonz Limited stock?

Curonz Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Curonz Limited's last funding round?

Curonz Limited's most recent funding round was Grant on December 11, 2015.

Who are the main investors in Curonz Limited?

Key investors in Curonz Limited include Callaghan Innovation, National MS Society.

Will Curonz Limited IPO soon?

No public IPO plans have been announced for Curonz Limited.

How can I track Curonz Limited secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Curonz Limited's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew Zealand
Employee Range1
Year Founded2009
Last FundingDec 11, 2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?